| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Announcements
|
|
|
1995
|
17 |
5S1 |
p. S521-
1 p.
|
artikel
|
| 2 |
Efficacy and safety of drugs for Paget's disease of bone
|
Reginster, J.-Y.L.
|
|
1995
|
17 |
5S1 |
p. S485-S488
4 p.
|
artikel
|
| 3 |
Human pharmacokinetics of tiludronate
|
Sansom, L.N.
|
|
1995
|
17 |
5S1 |
p. S479-S483
5 p.
|
artikel
|
| 4 |
Osteoporosis: Diagnosis and management today and tomorrow
|
Christiansen, C.
|
|
1995
|
17 |
5S1 |
p. S513-S516
4 p.
|
artikel
|
| 5 |
Skeletal safety of tiludronate
|
Neer, R.M.
|
|
1995
|
17 |
5S1 |
p. S501-S503
3 p.
|
artikel
|
| 6 |
The methodology of clinical trials of oral tiludronate in Paget's disease of bone
|
Roux, C.
|
|
1995
|
17 |
5S1 |
p. S497-S499
3 p.
|
artikel
|
| 7 |
Therapeutic strategy in Paget's disease of bone
|
Meunier, P.J.
|
|
1995
|
17 |
5S1 |
p. S489-S491
3 p.
|
artikel
|
| 8 |
The worldwide problem of osteoporosis: Insights afforded by epidemiology
|
Riggs, B.L.
|
|
1995
|
17 |
5S1 |
p. S505-S511
7 p.
|
artikel
|
| 9 |
Tiludronate: Bone pharmacology and safety
|
Bonjour, J-P.
|
|
1995
|
17 |
5S1 |
p. S473-S477
5 p.
|
artikel
|
| 10 |
Tiludronate: Development as an osteoporosis therapy
|
Chesnut III, C.H.
|
|
1995
|
17 |
5S1 |
p. S517-S519
3 p.
|
artikel
|
| 11 |
Tiludronate for bone diseases Proceedings of a satellite symposium held at the XIIth international conference on calcium regulating hormones (ICCRH), Melbourne, Australia, 14 February, 1995
|
Chesnut III, C.H.
|
|
1995
|
17 |
5S1 |
p. S471-
1 p.
|
artikel
|
| 12 |
Tiludronate therapy for Paget's disease of bone
|
McClung, M.R.
|
|
1995
|
17 |
5S1 |
p. S493-S496
4 p.
|
artikel
|
Tijdschrift beschrijving